Fierce Biotech13d
Neumora halts trial of depression drug, rethinks 2 others to apply lessons from phase 3 failure
Neumora halted one trial of its depression drug navacaprant and paused a pair of late-stage studies as it tries to learn from ...
Business Wire10d
Tris Pharma Announces Positive Results from ALLEVIATE-2 Phase 3 Pivotal Trial for Cebranopadol, an Investigational First-in-Class Oral Dual-NMR Agonist, for the Trea…
Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ...